Other and Special SituationsSpecial Situation AlertSep 18, 2026 · 4:03am ET
TCRTAlaunos Therapeutics, Inc.
Alaunos Therapeutics Files Patent Application for Neoantigen-Reactive T Cell Receptors
The filing was made to protect the company's intellectual property in the field of immunotherapy.